Evidence map›Paper›PMID 35327646›Full record

ReviewBiomolecules2022

Histamine Intolerance-A Kind of Pseudoallergic Reaction.

Ying Zhao, Xiaoyan Zhang, Hengxi Jin, Lu Chen, Jiang Ji, Zhongwei Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Clinical Outcomes and Food Triggers Following Low Food Chemical Diet Implementation: A Retrospective Audit of Dietetic Practice.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2025
    Article
  9. Evidence for Dietary Management of Histamine Intolerance.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ying ZhaoDepartment of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China.ORCID 0000-0003-2232-8026
Xiaoyan ZhangDepartment of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China.ORCID 0000-0001-6737-0311
Hengxi JinDepartment of Dermatology and Venereology, Suzhou Medical College of Soochow University, Suzhou 215000, China.ORCID 0000-0001-7016-8958
Lu ChenDepartment of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China.
Jiang JiDepartment of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China.
Zhongwei ZhangDepartment of Biochemistry and Molecular Biology, School of Medicine, Nantong University, Nantong 226001, China.ORCID 0000-0002-5590-0060
Soochow University · CNNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histamine intolerance (HIT) is a common disorder associated with impaired histamine metabolism. Notwithstanding, it is often misdiagnosed as other diseases because of its lack of specific clinical manifestations. HIT did not gain traction until the early 21st century. In this review, we will focus on the latest research and elaborate on the clinical manifestations of HIT, including its manifestations in special populations such as atopic dermatitis (AD) and chronic urticaria (CU), as well as the latest understanding of its etiology and pathogenesis. In addition, we will explore the latest treatment strategies for HIT and the treatment of specific cases.

Indexed as

Amine Oxidase (Copper-Containing)Dermatitis, AtopicHypersensitivityHistamineHumansAmine Oxidase (Copper-Containing)Histaminediamine oxidase (DAO)differential diagnosis of HIThistaminehistamine intolerance (HIT)treatment of HIT

Identifiers

PMID35327646
PMCPMC8945898
OpenAlexW4220718960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.